HUM-MOLGEN archive: HUM-MOLGEN News Alert

__________________________________________________________________________ CHI's Fourth Annual Discovery on Target: Target Discovery & Target Validation Strategies October 23-26, 2006 | World Trade Center | Boston, MA => http://hum-molgen.org/promotion-DoT Designed to expand the coverage of science and business strategies, this event will focus on disease target identification and effectiveness __________________________________________________________________________ INTERNATIONAL COMMUNICATION FORUM IN HUMAN MOLECULAR GENETICS HUM-MOLGEN News Alert - August 03, 2006 - http://hum-molgen.org Genetic News by T.M. D'Souza, S. Chandler, T. Dalaya, K. Markey, J. Mill, La Merie S.L, R. Nemade, D. Sharma, F.S. Zollmann http://hum-molgen.org/NewsGen - Promising Therapy For ALS Delivers Antisense Drug Directly To Nervous System Delivering agents across the blood-brain barrier likely to be effective treatment for other neurodegenerative diseases http://hum-molgen.org/NewsGen/08-2006/msg12.html - Cheap fast way to crack genome code US and Australian scientists have pioneered a new hybrid method for genomic sequencing that is faster and cheaper than state of the art technologies. http://hum-molgen.org/NewsGen/08-2006/msg11.html - Neutralizing HIV Study reveals the interaction between a human antibody and a protein found on the surface of the HIV-1 virus. http://hum-molgen.org/NewsGen/08-2006/msg10.html - Gleevec May Cause Heart Problems Imatinib mesylate (Gleevec), a drug used to treat chronic myelogenous leukemia (CML), can kill heart cells. http://hum-molgen.org/NewsGen/08-2006/msg09.html - Inhibiting Inflammation In Multiple Sclerosis T cells, a type of immune cell, can impede the development and progression of multiple sclerosis in mice. http://hum-molgen.org/NewsGen/08-2006/msg08.html - Mouse Model Suggests Treatment Strategy For Muscular Dystrophy Study reports a reversible mouse model of myotonic dystrophy, the most common form of muscular dystrophy in adults. http://hum-molgen.org/NewsGen/08-2006/msg07.html - Receptors In The Mouse Nose May Be Pheromone Detectors Biologists have discovered a second set of olfactory receptors in the mouse nose, including ones that may detect pheromones and might therefore aid in the mating game. http://hum-molgen.org/NewsGen/08-2006/msg06.html - Choosing Face Study clarifies the role of particular neurons in a region of monkeys' brains known to be important for object recognition. http://hum-molgen.org/NewsGen/08-2006/msg05.html - Active Sites Of A Hepatitis C Virus Enzyme Revealed The crystal structure of one of the hepatitis C viral proteins could offer new opportunities for antiviral drug design. http://hum-molgen.org/NewsGen/08-2006/msg04.html - Unexpected Inheritance Research supports the idea that RNA partly determines the inherited characteristics of plants and animals. http://hum-molgen.org/NewsGen/08-2006/msg03.html - Melanoma Risk Linked to the Gene for the Melanocortin-1 Receptor and Sun Exposure MC1R gene variants are correlated with BRAF mutations and the risk of melanoma with intermittent exposure to sunlight. http://hum-molgen.org/NewsGen/08-2006/msg02.html - A Full Pipeline of Follow-on TNF-Antagonists The US$ 7.6 bln market of TNF-antagonists attracts numerous follow-on compounds including improved TNF-antagonists and molecules originating from new technologies http://hum-molgen.org/NewsGen/08-2006/msg01.html - New Genomes to be Targeted for Sequencing United States' National Human Genome Research Institute Large Scale Sequencing Research Network adds more animal genomes to it's To Do List. http://hum-molgen.org/NewsGen/07-2006/msg32.html - New Blood Test for the Prediction and Complications of Sickle Cell Disease Brain natriuretic peptide or BNP is a hormone whose levels might also correlate with the severity of pulmonary hypertension and risk of death in sickle cell patients. http://hum-molgen.org/NewsGen/07-2006/msg31.html - Contact Genetic News editors WWW: http://hum-molgen.org/editors.html E-mail: news@hum-molgen.org DIAGnostics - Clinical Research (professional requests) http://hum-molgen.org/clinical-research/ - Post diagnostic request / call for collaboration http://hum-molgen.org/diagnostic-posting or contact admin@hum-molgen.org Biotechnical requests and sources http://hum-molgen.org/biotechnology - Post request or source http://hum-molgen.org/biotechnical-request-posting Biomedical Positions http://hum-molgen.org/positions/ - Cancer Research: POST-DOCTORAL FELLOW INSERM EMI229, Montpellier, 34298 Cedex 5, France http://hum-molgen.org/positions/postdocs/2622.html - Cell and Molecular Biology / Anatomy: PhD studentship and Postdoctoral Position Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain http://hum-molgen.org/positions/postdocs/2624.html - Genetics: Scientist - Genotyping Idenix Pharmaceuticals, Cambridge, MA, USA http://hum-molgen.org/positions/postdocs/2621.html - Genetics: Post Doctoral Fellow Roswell Park Cancer Institute, Buffalo, NY 14263, USA http://hum-molgen.org/positions/postdocs/2623.html - Write a position announcement http://hum-molgen.org/flyer/positions.pdf 1) Set up account: http://hum-molgen.de/cgi-bin/positions.pl?register 2) Post position(s): http://hum-molgen.de/cgi-bin/positions.pl?login Literature http://hum-molgen.org/literature/ Events in bioscience and medicine http://hum-molgen.org/meetings/ - Post event (free) http://hum-molgen.de/cgi-bin/meetings.pl?login Registry of Biomedical Companies (1229 active entries) http://hum-molgen.org/companies/ Mailing List Administration (Join or leave the list) http://hum-molgen.org/subscribe-na/ Feedback contact admin@hum-molgen.org Advertise at HUM-MOLGEN http://hum-molgen.org/flyer/advertise.pdf contact FS Zollmann (dialogue@hum-molgen.org) __________________________________________________________________________ CHI's Fourth Annual Discovery on Target: Target Discovery & Target Validation Strategies October 23-26, 2006 | World Trade Center | Boston, MA => http://hum-molgen.org/promotion-DoT Designed to expand the coverage of science and business strategies, this event will focus on disease target identification and effectiveness. Discovery on Target will continue its tradition of offering the highest caliber scientific content with increased time for networking and discussion. The Executive Track will concentrate on the heart of current strategic business issues important to target discovery. Discovery on Target 2006 offers: Inaugural Ion Channels Second Annual Preclinical Disease Models Fourth Annual RNAi Second Annual Executive on Target Sixth Annual Chemogenomics PLUS! Pre-Conference Short Courses Second Annual Regulomics Symposium __________________________________________________________________________